Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
Status unconfirmed · Phase 3
Conditions studied: Head and Neck Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if treatment with cisplatin plus epinephrine is effective for head and neck cancer. PURPOSE: Randomized double-blinded phase III trial to determine the effectiveness of cisplatin plus epinephrine in injectable gel form in treating patients who have recurrent or refractory head and neck cancer.
Key facts
- Study ID
- NCT00002659
- Run by
- Matrix Pharmaceutical
- People needed
- 120
- Starts
- 1995-05-01
- Last updated by the study team
- 2013-12-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Veterans Affairs Medical Center - Tucson — Tucson, Arizona, United States
- Arizona Cancer Center — Tucson, Arizona, United States
- Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
- Veterans Affairs Medical Center - Palo Alto — Palo Alto, California, United States
- UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
- Stanford University Medical Center — Stanford, California, United States
- Comprehensive Cancer Center at JFK Medical Center — Atlantis, Florida, United States
- Sylvester Cancer Center, University of Miami — Miami, Florida, United States
- Evanston Northwestern Health Care — Evanston, Illinois, United States
- University of Kansas Medical Center — Kansas City, Kansas, United States
- University of Kentucky College of Medicine — Lexington, Kentucky, United States
- Louisiana State University Medical Center - New Orleans — New Orleans, Louisiana, United States
- Louisiana State University Hospital - Shreveport — Shreveport, Louisiana, United States
- Veterans Affairs Medical Center - Baltimore — Baltimore, Maryland, United States
- Capitol Comprehensive Cancer Care Clinic — Jefferson City, Missouri, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Methodist Cancer Center - Omaha — Omaha, Nebraska, United States
- Creighton University Cancer Center — Omaha, Nebraska, United States
- University of New Mexico Cancer Research & Treatment Center — Albuquerque, New Mexico, United States
- Oregon Cancer Center at Oregon Health Sciences University — Portland, Oregon, United States
- Palmetto Richland Memorial Hospital — Columbia, South Carolina, United States
- Thompson Cancer Survival Center — Knoxville, Tennessee, United States
- Boston Cancer Group — Memphis, Tennessee, United States
- Southwest Regional Cancer Center — Austin, Texas, United States
- University of Texas Southwestern Medical School — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.